Spyre Therapeutics, Inc. · NASDAQ:SYRE

Tang Capital Management LLC reported a 5.30% stake in Spyre Therapeutics, Inc. (Schedule 13G)

Event Apr 24, 2025 · Filed May 1, 2025

Tang Capital Management LLC reported a 5.30% stake in Spyre Therapeutics, Inc., 3,200,000 shares, as a passive investor on Apr 24, 2025. Filed May 1, 2025 (Schedule 13G).

Stake
5.30%
Shares
3,200,000
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
TANG CAPITAL MANAGEMENT, LLC5.30%3,200,000
KEVIN TANG5.30%3,200,000
TANG CAPITAL PARTNERS, LP3.00%1,799,658
TANG CAPITAL PARTNERS INTERNATIONAL, LP2.30%1,400,342
TANG CAPITAL PARTNERS III, INC0%0
TANG CAPITAL PARTNERS IV, INC0%0

Source

View original at SEC

Related